Massachusetts Financial Services CO Blueprint Medicines Corp Transaction History
Massachusetts Financial Services CO
- $299 Billion
- Q4 2024
A detailed history of Massachusetts Financial Services CO transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Massachusetts Financial Services CO holds 269,990 shares of BPMC stock, worth $27.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
269,990
Previous 252,236
7.04%
Holding current value
$27.4 Million
Previous $23.3 Million
0.97%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BPMC
# of Institutions
362Shares Held
61.8MCall Options Held
2.24MPut Options Held
1.15M-
Vanguard Group Inc Valley Forge, PA6.77MShares$688 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$675 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$547 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$435 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$281 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.07B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...